{"": [85, 1226, 0], "COVID-19 pandemic and its countermeasures": [1227, 4340, 0], "Non-human primates": [5647, 8047, 0], "Syrian hamsters": [8048, 10336, 0], "Ferrets": [10337, 11896, 0], "Minks": [11897, 13725, 0], "Mice": [13726, 14406, 0], "Animal models for SARS-CoV-2": [4341, 14406, 1], "Mouse models for COVID-19": [14407, 17738, 0], "Adenovirus vectors": [18628, 20520, 0], "Benefits and limitations of transient mouse models": [20521, 22332, 0], "Mouse models based on transient hACE2 expression": [17739, 22332, 1], "K18-hACE2 mice": [22661, 25756, 0], "AC70 mice": [25757, 26897, 0], "hACE2 mice": [26898, 28093, 0], "HFH4-hACE2 mice": [28094, 30223, 0], "Knock-in mice": [30224, 31369, 0], "Benefits and limitations of transgenic mouse models": [31370, 32323, 0], "Mouse-adapted SARS-CoV-2": [32324, 33848, 0], "Benefits and limitations of mouse-adapted SARS-CoV-2 strains": [33849, 34990, 0], "SASRS-CoV-2-specific immunity: T cells": [34991, 43266, 0], "Next-generation mouse models": [43267, 46784, 0], "Mouse models based on transgenic hACE2 expression": [22333, 46784, 1]}